In order to meet the needs of the imported drugs, further improve the supply of drugs, improve the domestic level of medical treatment and improve the health of the people, the adjustment will abolish the import duties of the 28 drugs. After the adjustment, the vast majority of imported drugs, especially the anticancer drugs that have actual imports, will achieve zero tariffs, except for a small number of special products and some alkaloid drugs in China. With a large reduction in the value added tax in the production and import of anticancer drugs, a number of comprehensive measures, such as centralized government procurement, import of innovative drugs, especially anticancer drugs into the catalogue of medical insurance reimbursement, and the acceleration of the import and export of innovative drugs, will be further reduced, which will further reduce the drugs of domestic patients, especially cancer patients. The cost burden and the choice of more drugs. The tax reduction is a new initiative to better meet the peoples health needs, to maintain an open and inclusive multilateral trading system and to create shared development results.